Insider · CIK 0001966598
Neil J Fernandes
Files at LRCX (LAM RESEARCH CORP). First filing Feb 2, 2024, latest Jun 2, 2026.
In brief
Neil J Fernandes files SEC Form 4 as officer at LRCX (LAM RESEARCH CORP). Since Feb 2, 2024, Neil J Fernandes has reported 0 open-market buys worth $0 and 3 open-market sells worth $8.8M, the latest filed on Jun 2, 2026.
A track record needs three past buys with six months of prices behind them; Neil J Fernandes has 0, so none is measured yet.
The newest scored trade: sold $2.4M of LRCX on Jun 1, 2026, filed Jun 2, 2026, scored 33 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $7.0M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LRCX: LAM RESEARCH CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | LAM RESEARCH CORP | $2.4M 7,659 shares | -12% | +287% from low-2% from high | |
| 33Weak | LAM RESEARCH CORP | $4.6M 18,170 shares | -22% | +261% from low-6% from high | |
| 45Moderate | LRCXsell LAM RESEARCH CORP | $1.8M 2,161 shares | -18% | +77% from low-4% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 1, 2026 | LRCX LAM RESEARCH CORP | 7,659 0.00% of outstanding | $2.4M | Jun 1, 2026 | $4.6M |
| May 1, 2026 | LRCX LAM RESEARCH CORP | 18,170 0.00% of outstanding | $4.6M | May 1, 2026 | none |
| Jul 12, 2024 | LRCX LAM RESEARCH CORP | 1,620 0.00% of outstanding | $1.7M | Jul 12, 2024 | none |
| Feb 1, 2024 | LRCX LAM RESEARCH CORP | 2,161 0.00% of outstanding | $1.8M | Feb 1, 2024 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -7,659 | $309.60 | $2.4M | 58,470 | Jun 2, 2026 |
| May 1, 2026 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -18,170 | $255.14 | $4.6M | 66,129 | May 4, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | AGrant or award Common Stock | +8,274 | $0.00 | $0 | 101,042 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -10,694 | $233.89 | $2.5M | 90,348 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -1,298 | $233.89 | $304k | 89,050 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -1,809 | $233.89 | $423k | 87,241 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -3,290 | $233.89 | $769k | 83,951 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | AGrant or award Market-based Performance Restricted Stock Unitderivative | +10,113 | $0.00 | $0 | 10,113 | Mar 2, 2026 |
| Feb 3, 2026 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock | +21,570 | $0.00 | $0 | 92,768 | Feb 5, 2026 |
| Feb 3, 2026 | LRCX LAM RESEARCH CORP | MOption exercise Market-based Performance Restricted Stock Unitderivative | -14,380 | $0.00 | $0 | 0 | Feb 5, 2026 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | AGrant or award Common Stock | +19,913 | $0.00 | $0 | 77,090 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -1,725 | $76.74 | $132k | 75,365 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -1,398 | $76.74 | $107k | 73,967 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -1,294 | $76.74 | $99k | 72,673 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -1,809 | $76.74 | $139k | 70,864 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | AGrant or award Market-based Performance Restricted Stock Unitderivative | +24,339 | $0.00 | $0 | 24,339 | Mar 4, 2025 |
| Feb 4, 2025 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock | +4,805 | $0.00 | $0 | 57,177 | Feb 6, 2025 |
| Feb 4, 2025 | LRCX LAM RESEARCH CORP | MOption exercise Market-based Performance Restricted Stock Unitderivative | -8,440 | $0.00 | $0 | 0 | Feb 6, 2025 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | AGrant or award Common Stock | +1,095 | $0.00 | $0 | 12,091 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -448 | $981.53 | $440k | 11,643 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -150 | $981.53 | $147k | 11,493 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -139 | $981.53 | $136k | 11,354 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -129 | $981.53 | $127k | 11,225 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | AGrant or award Market-based Performance Restricted Stock Unitderivative | +2,009 | $0.00 | $0 | 2,009 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | AGrant or award Employee Stock Option (Right to Buy)derivative | +1,641 | $0.00 | $0 | 1,641 | Mar 5, 2024 |
| Feb 6, 2024 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock | +1,088 | $0.00 | $0 | 10,996 | Feb 8, 2024 |
| Feb 6, 2024 | LRCX LAM RESEARCH CORP | MOption exercise Market-based Performance Restricted Stock Unitderivative | -908 | $0.00 | $0 | 0 | Feb 8, 2024 |
| Feb 1, 2024 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock | -2,161 | $828.33 | $1.8M | 9,908 | Feb 2, 2024 |
Questions about Neil J Fernandes
Answered from the filings on this page, as of the latest one.
Is Neil J Fernandes buying or selling?
In the last 12 months Neil J Fernandes reported 0 open-market buys worth $0 and 2 open-market sells worth $7.0M on SEC Form 4; the latest was sold $2.4M of LRCX on Jun 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Neil J Fernandes's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neil J Fernandes has 0.
Where does Neil J Fernandes file Form 4?
Neil J Fernandes has filed Form 4 at LRCX (LAM RESEARCH CORP) as Senior Vice President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.